<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Measles can be effectively prevented through vaccination, typically given in combination with vaccines for rubella (MR), mumps (MMR), or varicella (MMR-V). WHO recommends the first dose of measles vaccine be administered at 9 or 12 months of age in high and low prevalence settings, respectively [
 <xref ref-type="bibr" rid="CR138">138</xref>]. A second dose should be administered after a minimum of 4-week interval. Nonimmune individuals that have been exposed to measles should receive post-exposure prophylaxis with MMR or immunoglobulin within 72 hours or 6 days, respectively, although not concurrently [
 <xref ref-type="bibr" rid="CR139">139</xref>]. Clinical management of patients with measles consists of fluid, electrolyte, and nutritional support and early recognition and treatment of bacterial coinfection [
 <xref ref-type="bibr" rid="CR10">10</xref>]. Two doses of vitamin A inchildren under 2 years have been associated with reduced risk of pneumonia and death [
 <xref ref-type="bibr" rid="CR140">140</xref>]. WHO recommends administering 200,000 IU of vitamin A daily for 2 days in children aged 1 year and older, with reduced dosingin younger infants [
 <xref ref-type="bibr" rid="CR141">141</xref>].
</p>
